ARCHIVES

Richard Pazdur’s Comments to ODAC

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Peter Jones begins term as AACR president-elect. New directors elected.

April 2, 2004

NCI CTEP Approved Trials For the Month of January

January 25, 2013

Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs

July 29, 1983

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

Cooperative Group Chairmen, OPRR Seek Agreement On Assurances

January 6, 1984